Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 2/20 | 0.50 |
| ▸ | SCD | O00767 | 2/20 | 0.49 |
| ▸ | SCD5 | Q86SK9 | 2/20 | 0.49 |
| ▸ | DRD2 | P14416 | 5/20 | 0.47 |
| ▸ | DRD3 | P35462 | 5/20 | 0.47 |
| ▸ | ROCK2 | O75116 | 5/20 | 0.46 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | NOTCH1 | P46531 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL456382 | 1.00 | RIPK1 (0.50) | RIPK1SCDSCD5DRD2DRD3 | |
| SCHEMBL31421008 | 0.85 | GPR119 (0.51) | RIPK1SCD5 | |
| SCHEMBL878861 | 0.83 | NPSR1 (0.56) | RIPK1SCD5ROCK2TSHR | |
| SCHEMBL469821 | 0.83 | RIPK1 (0.46) | RIPK1 | |
| SCHEMBL17067861 | 0.83 | RIPK1 (0.46) | RIPK1 | |
| SCHEMBL17067869 | 0.82 | RIPK1 (0.73) | RIPK1SCD5TSHR | |
| SCHEMBL22505052 | 0.82 | USP30 (0.53) | RIPK1SCD5ROCK2TSHR | |
| SCHEMBL21198773 | 0.82 | RIPK1 (0.53) | RIPK1TSHR | |
| SCHEMBL21207072 | 0.82 | RIPK1 (0.53) | RIPK1TSHR | |
| SCHEMBL469686 | 0.82 | RIPK1 (0.73) | RIPK1SCD5TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012034095-A1 | COMPOUNDS AND COMPOSITIONS AS TRK INHIBITORS | IRM LLC (BM) | 2012-03-15 | — | — | WO | disclosed |